Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02050191
Other study ID # 2005-10
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2006
Est. completion date May 2012

Study information

Verified date March 2020
Source Griffin Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study supports the development of a diabetes prevention and control community web portal. The portal will feature an innovative personalized impediment profiling tool and reward program. The program, "Nutrition Navigation on-Line Edge," or NnoLEDGE, will be used by community consortiums for weight loss and diabetic health interventions within their communities.

The Specific Aims are:

1. Recruitment of local community organizations to participate as a community health consortium

2. Development of a comprehensive community health web portal consisting of a web portal, impediment profiler, community toolbox, and rewards system

3. Final evaluation of the system with regard to participants' attitudes and perceptions of using NnoLEDGE as a tool for weight control and diabetes prevention to determine feasibility.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date May 2012
Est. primary completion date May 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- can read and write English

Exclusion Criteria:

- cannot read and write Engish

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
www.princetonlivingwell.com


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Griffin Hospital Viocare, Inc.

Outcome

Type Measure Description Time frame Safety issue
Primary attitudes and perceptions re: feasibility of web portal Subjects will complete surveys aimed at assessing their attitudes and perceptions of the feasibility of the use of the nNoledge tool for weight control and prevention of diabetes 2 months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2